Cargando…
The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligom...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512837/ https://www.ncbi.nlm.nih.gov/pubmed/35970390 http://dx.doi.org/10.1016/j.jbc.2022.102370 |
_version_ | 1784797921035681792 |
---|---|
author | Zapata-Mercado, Elmer Biener, Gabriel McKenzie, Daniel M. Wimley, William C. Pasquale, Elena B. Raicu, Valerica Hristova, Kalina |
author_facet | Zapata-Mercado, Elmer Biener, Gabriel McKenzie, Daniel M. Wimley, William C. Pasquale, Elena B. Raicu, Valerica Hristova, Kalina |
author_sort | Zapata-Mercado, Elmer |
collection | PubMed |
description | The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligomers upon ligand binding. Here, we investigated if a correlation exists between EphA2 signaling properties and the size of the EphA2 oligomers induced by multiple ligands, including the widely used ephrinA1-Fc ligand, the soluble monomeric m-ephrinA1, and novel engineered peptide ligands. We used fluorescence intensity fluctuation (FIF) spectrometry to characterize the EphA2 oligomer populations induced by the different ligands. Interestingly, we found that different monomeric and dimeric ligands induce EphA2 oligomers with widely different size distributions. Our comparison of FIF brightness distribution parameters and EphA2 signaling parameters reveals that the efficacy of EphA2 phosphorylation on tyrosine 588, an autophosphorylation response contributing to EphA2 activation, correlates with EphA2 mean oligomer size. However, we found that other characteristics, such as the efficacy of AKT inhibition and ligand bias coefficients, appear to be independent of EphA2 oligomer size. Taken together, this work highlights the utility of FIF in RTK signaling research and demonstrates a quantitative correlation between the architecture of EphA2 signaling complexes and signaling features. |
format | Online Article Text |
id | pubmed-9512837 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-95128372022-09-30 The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size Zapata-Mercado, Elmer Biener, Gabriel McKenzie, Daniel M. Wimley, William C. Pasquale, Elena B. Raicu, Valerica Hristova, Kalina J Biol Chem Methods and Resources The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligomers upon ligand binding. Here, we investigated if a correlation exists between EphA2 signaling properties and the size of the EphA2 oligomers induced by multiple ligands, including the widely used ephrinA1-Fc ligand, the soluble monomeric m-ephrinA1, and novel engineered peptide ligands. We used fluorescence intensity fluctuation (FIF) spectrometry to characterize the EphA2 oligomer populations induced by the different ligands. Interestingly, we found that different monomeric and dimeric ligands induce EphA2 oligomers with widely different size distributions. Our comparison of FIF brightness distribution parameters and EphA2 signaling parameters reveals that the efficacy of EphA2 phosphorylation on tyrosine 588, an autophosphorylation response contributing to EphA2 activation, correlates with EphA2 mean oligomer size. However, we found that other characteristics, such as the efficacy of AKT inhibition and ligand bias coefficients, appear to be independent of EphA2 oligomer size. Taken together, this work highlights the utility of FIF in RTK signaling research and demonstrates a quantitative correlation between the architecture of EphA2 signaling complexes and signaling features. American Society for Biochemistry and Molecular Biology 2022-08-13 /pmc/articles/PMC9512837/ /pubmed/35970390 http://dx.doi.org/10.1016/j.jbc.2022.102370 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Methods and Resources Zapata-Mercado, Elmer Biener, Gabriel McKenzie, Daniel M. Wimley, William C. Pasquale, Elena B. Raicu, Valerica Hristova, Kalina The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size |
title | The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size |
title_full | The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size |
title_fullStr | The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size |
title_full_unstemmed | The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size |
title_short | The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size |
title_sort | efficacy of receptor tyrosine kinase epha2 autophosphorylation increases with epha2 oligomer size |
topic | Methods and Resources |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512837/ https://www.ncbi.nlm.nih.gov/pubmed/35970390 http://dx.doi.org/10.1016/j.jbc.2022.102370 |
work_keys_str_mv | AT zapatamercadoelmer theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT bienergabriel theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT mckenziedanielm theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT wimleywilliamc theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT pasqualeelenab theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT raicuvalerica theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT hristovakalina theefficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT zapatamercadoelmer efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT bienergabriel efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT mckenziedanielm efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT wimleywilliamc efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT pasqualeelenab efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT raicuvalerica efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize AT hristovakalina efficacyofreceptortyrosinekinaseepha2autophosphorylationincreaseswithepha2oligomersize |